Health Care/Hospital
Beyond Wearables: Dreame Unveils Your AI-Driven Proactive Health Ecosystem at CES 2026
Dreame Redefines Wearable Technology at CES 2026 with Full-Scenario Health
Ecosystem
LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- Dreame Technology
2026-01-08 14:38
3703
LumiMind To Showcase Groundbreaking Non-Invasive BCI Technology With Live Gameplay Demo at CES 2026
LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- LumiMind, a next-generation neurotechnology company pioneering non-invasive, real-time neural modulation, will showcase breakthrough brain–computer interface (BCI) technology atCES 2026 inLas Vegas, including a live, real-time gameplay demonstration develop...
2026-01-08 13:51
151
Appotronics Showcases Hair Regrowth and Skincare Series at CES 2026, Inspiring Hope for Millions
LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- At CES 2026, Appotronics, the inventor of ALPD® laser technology, is showcasing its first-ever series of laser-care products for the personal-wellness industry – with products that aim to deliver life-changing hair-regrowth and skin-rejuvenation. The trio ...
2026-01-08 12:12
2615
Eight Years at the Top: USANA Malaysia Named #1 Combination Dietary Supplements Brand by Euromonitor International
KUALA LUMPUR, Malaysia, Jan. 8, 2026 /PRNewswire/ -- USANA Malaysia has once again been awarded the title of Top #1 Combination Dietary Supplements in Malaysia by global market research leader Euromonitor International. This achievement marks eight consecutive years that the market has earned the...
2026-01-08 08:13
2493
Arbele Receives FDA Orphan Drug Designation for ARB1002, an Anti-CDH17 Antibody-Drug Conjugate for the Treatment of Pancreatic Cancer
SEATTLE, Jan. 7, 2026 /PRNewswire/ -- Arbele, a biotechnology company focused on developing innovative targeted cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ARB1002, its investigational antibody-drug conjugate (ADC...
2026-01-08 00:00
3412
Sensura to Showcase Non-Invasive Health Monitoring Platform, Starting with Glucose, at CES 2026
LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- Sensura, a Singapore-based deep-tech company focused on next-generation health and wellness monitoring, today announced that it will showcase its non-invasive health monitoring platform, starting with glucose, atCES 2026, taking place from January 6–9, 2026...
2026-01-07 11:18
3475
Ivonescimab's Updated Label Shows Positive Dual Results in PFS and OS from HARMONi-A Study
HONG KONG, Jan. 6, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced that the National Medical Products Administration has approved a significant label update inChina for its internally developed, first-in-class PD-1/VEGF bispecific antibody, ivonescimab. The updated label incorporates final a...
2026-01-07 10:50
4872
Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies
CHENGDU, China, Jan. 6, 2026 /PRNewswire/ -- The 44th J.P. Morgan Healthcare Conference (JPMHC) will be held inSan Francisco, California, USA, from January 12 to 15, 2026. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) has been invited to attend the ...
2026-01-07 10:44
4721
HealthBiome Achieves Dual Regulatory Milestones: FDA NDI Acknowledgment and Korean MFDS Approval for HB05P Muscle Health Ingredient
Akkermansia muciniphila postbiotic receives both U.S. FDA dietary supplement clearance and Korean functional ingredient approval with muscle health claim, positioning HealthBiome for dual-market launch in 2026 DAEJEON, South Korea, Jan. 6, 2026 /PRNewswire/ -- HealthBiome Inc., a pioneering stri...
2026-01-07 08:00
3528
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
INCHEON, South Korea, Jan. 6, 2026 /PRNewswire/ -- Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced that Jin-Seok Seo, Chief Executive Officer andHyuk-Jae Lee, Senior Executive Vice President at Celltrion, will present at the 44th Annual J.P. Morgan Healthc...
2026-01-07 07:42
5348
Nuon Medical Unveils Tech-Integrated Packaging Ecosystem at CES 2026, Engineering Clinical Precision into the Point of Skin Contact
LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- Nuon Medical, a leader in beauty tech
innovation, has announced a comprehensive tech-integrated packaging ecosystem
at CES 2026.
2026-01-07 01:00
220
Mind With Heart Robotics Showcases Emotionally Intelligent Robot Lineup at CES 2026, Including CES Innovation Award Honoree An'An Biomimetic Affective AI Panda
Company Expands Therapeutic Robotics Comprehensive Product Lineup Addressing Diverse Emotional and Clinical Support Needs LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- Mind With Heart Robotics Co., Ltd. showcases its comprehensive lineup of emotionally intelligent robots that mimic natural movements, ...
2026-01-07 01:00
589
Expanding Healthcare Access for Women's Health -- Noul Unveils AI-Automated Cervical Cancer Diagnostics Solution at CES 2026
* Dramatically cuts diagnostic workflows by 80%…delivering results in under 20 minutes * Decentralized, fully automated diagnostic model helps reduce healthcare infrastructure gaps and supports WHO's 2030 cervical cancer screening goals * Eco-friendly, sustainable AI diagnostics with NGSI so...
2026-01-07 01:00
316
VivaVision Biotech Receives Positive Written Feedback from FDA - VVN461HD New Drug Application (NDA) Requires Only a "Single Phase III" Pivotal Clinical Study in the U.S. for Non-Infectious Anterior Uveitis Treatment
WENZHOU, China, Jan. 6, 2026 /PRNewswire/ -- Recently, VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced that it has received the written meeting minutes from the U.S. Food and Drug Administration (F...
2026-01-07 00:00
160
Bambusa Therapeutics Announces First Patient Dosed in Phase Ib Proof-of-Concept COPD Study of BBT002, Reinforcing Bispecific Pipeline Momentum
BOSTON, Jan. 6, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc., a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology & inflammation (I&I), today announceddosing of the first patient in the Phase Ib clinical trial of BBT002, a novel platform-in-a...
2026-01-06 22:30
186
Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology
- New, retractable safety hypodermic line offers enhanced safety, reliability and ease of use while minimizing patient discomfort* - SOMERSET, N.J., Jan. 6, 2026 /PRNewswire/ -- Terumo Medical Corporation, a wholly-owned subsidiary of Terumo Corporation, announced the US launch of its SurTract™ ...
2026-01-06 21:29
1840
Zpeer Launches A-DHA-PT™, a High-Concentration DHA Supplement for Dogs, and Announces Research Collaboration with the University of Tokyo
TOKYO, Jan. 6, 2026 /PRNewswire/ -- Zpeer Inc. (Headquarters: Shibuya, Tokyo; CEO:Toshiya Morino), an animal health company focused on evidence-based therapeutic innovation, has recently announced the launch of A-DHA-PT™ (pronounced "ay-dapt"), a high-concentration DHA supplement designed to supp...
2026-01-06 21:00
217
Xellar and WOOJUNG BIO Announce Multi-Year Strategic Partnership to Advance AI-Enabled Hybrid Human Organ-on-a-Chip (OoC)-Animal Preclinical Platforms
BOSTON and SEOUL, South Korea, Jan. 5, 2026 /PRNewswire/ -- Xellar Biosystems ("Xellar"), a globally leading innovator in next-generation artificial intelligence- and computer vision–assisted, organ-on-a-chip–based drug discovery and development platforms, today announced that it has entered into...
2026-01-06 08:00
3413
Nanjing Delova Announces Statistically Significant and Clinically Meaningful Results From Two Phase 3 Trials of QP-6211 for the Treatment of Postoperative Pain
* Treatment with QP-6211 achieved primary and all key secondary endpoints in both placebo- and active-controlled Phase 3 trials following hemorrhoidectomy or bunionectomy. * QP-6211 demonstrated statistically significant reductions in postoperative pain and opioid consumption through 72 hou...
2026-01-05 23:00
3395
Flat Medical Appoints Eric Steen, Former B. Braun Executive, as Strategic Advisor
Medical Device Industry Veteran to Guide Capital Strategy and Market Expansion AUSTIN, Texas and TAIPEI, Jan. 5, 2026 /PRNewswire/ -- Flat Medical, a leader in precision safety technology for clinical procedures, today announced the appointment ofEric Steen as Strategic Advisor. Mr. Steen brings ...
2026-01-05 21:30
3695
Week's Top Stories
Most Reposted
Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 309 media titles]
2026-03-04 12:35
SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 300 media titles]
2026-03-02 09:15Klook's Spring Readiness Index shows how Asia's travelers are preparing for spring travel across Japan, South Korea, and Mainland China
[Picked up by 291 media titles]
2026-03-03 15:49
Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
[Picked up by 290 media titles]
2026-03-02 09:00
COL and NASDAQ-Listed BeLive Holdings Unveil World's First "Microdrama in a Box" in Headline Hong Kong FILMART 2026 Launch
[Picked up by 287 media titles]
2026-03-05 17:14
Most Read
COLUMBIA ASIA HOSPITAL BUKIT JALIL LAUNCHES NEW CATH LAB TO STRENGTHEN HEART CARE SERVICES
2026-03-02 14:24
10769
